TYPTF (Entropy Neurodynamics) Common Stock: $27.02 Mil (As of Dec. 2025)


What is Entropy Neurodynamics Common Stock?

Entropy Neurodynamics TYPTF -45.63% Common Stock is $27.02 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Entropy Neurodynamics's quarterly common stock increased from Dec. 2024 ($20.56 Mil) to Jun. 2025 ($22.99 Mil) and increased from Jun. 2025 ($22.99 Mil) to Dec. 2025 ($27.02 Mil).

Entropy Neurodynamics's annual common stock increased from Jun. 2022 ($24.11 Mil) to Jun. 2023 ($24.65 Mil) but then declined from Jun. 2023 ($24.65 Mil) to Jun. 2025 ($22.99 Mil).

Entropy Neurodynamics Common Stock Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics Common Stock Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
Common Stock
Get a 7-Day Free Trial 8.80 26.22 24.11 24.65 22.99

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.65 24.58 20.56 22.99 27.02

Entropy Neurodynamics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $27.02 Mil mean?
Entropy Neurodynamics (TYPTF) has a Common Stock of $27.02 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Entropy Neurodynamics and its competitors.
Is Entropy Neurodynamics' Common Stock too high?
Entropy Neurodynamics' current Common Stock is $27.02 Mil.
How does Entropy Neurodynamics' Common Stock compare to VRTX and REGN?
Entropy Neurodynamics' Common Stock of $27.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current Common Stock is $27.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current Common Stock is $27.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Common Stock is $27.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.